Concepedia

L. Thorn

LT

8

Publications

341

Citations

8

H-Index

1991

Active since

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

MSD (UK) Limited (United Kingdom)

Molecular Discovery (United Kingdom)

L. Thorn is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in social sciences, neuropharmacology, and neuroscience.

Top concepts

Publications per year

1991–1997

8

Publications

8

The glycine/NMDA receptor antagonist, R‐(+)‐HA‐966, blocks activation of the mesolimbic dopaminergic system induced by phencyclidine and dizocilpine (MK‐801) in rodents

Linda J. Bristow, P.H. Hutson, L. Thorn et al. · British Journal of Pharmacology · 1993 · 94 citations · Full text

, , +20

R‐(+)‐HA‐966, a glycine/NMDA receptor antagonist, selectively blocks the activation of the mesolimbic dopamine system by amphetamine

Peter H. Hutson, Linda J. Bristow, L. Thorn et al. · British Journal of Pharmacology · 1991 · 75 citations · Full text

Anticonvulsant and behavioral profile of L-701,324, a potent, orally active antagonist at the glycine modulatory site on the N-methyl-D-aspartate receptor complex.

Linda J. Bristow, Peter H. Hutson, Janusz J. Kulagowski et al. · Journal of Pharmacology and Experimental Therapeutics · 1996 · 42 citations

The anticonvulsant and behavioural profile of L‐687,414, a partial agonist acting at the glycine modulatory site on the N‐methyl‐D‐aspartate (NMDA) receptor complex

Mark D. Tricklebank, Linda J. Bristow, Peter H. Hutson et al. · British Journal of Pharmacology · 1994 · 40 citations · Full text

Behavioural and biochemical evidence of the interaction of the putative antipsychotic agent, BMY 14802 with the 5-HT1A receptor

Linda J. Bristow, Lisa Baucutt, L. Thorn et al. · European Journal of Pharmacology · 1991 · 28 citations

, , +16

Rows per page

1–5 of 8